268 related articles for article (PubMed ID: 20213277)
1. Relaxin family peptide systems and the central nervous system.
Callander GE; Bathgate RA
Cell Mol Life Sci; 2010 Jul; 67(14):2327-41. PubMed ID: 20213277
[TBL] [Abstract][Full Text] [Related]
2. Relaxin-family peptide and receptor systems in brain: insights from recent anatomical and functional studies.
Ma S; Gundlach AL
Adv Exp Med Biol; 2007; 612():119-37. PubMed ID: 18161485
[TBL] [Abstract][Full Text] [Related]
3. RLN3/RXFP3 Signaling in the PVN Inhibits Magnocellular Neurons via M-like Current Activation and Contributes to Binge Eating Behavior.
Kania A; Szlaga A; Sambak P; Gugula A; Blasiak E; Micioni Di Bonaventura MV; Hossain MA; Cifani C; Hess G; Gundlach AL; Blasiak A
J Neurosci; 2020 Jul; 40(28):5362-5375. PubMed ID: 32532885
[TBL] [Abstract][Full Text] [Related]
4. Sex- and age-specific differences in relaxin family peptide receptor expression within the hippocampus and amygdala in rats.
Meadows KL; Byrnes EM
Neuroscience; 2015 Jan; 284():337-348. PubMed ID: 25313002
[TBL] [Abstract][Full Text] [Related]
5. [Relaxin-3 and relaxin family peptide receptors--from structure to functions of a newly discovered mammalian brain system].
Kania A; Lewandowski MH; Błasiak A
Postepy Hig Med Dosw (Online); 2014; 68():851-64. PubMed ID: 24988606
[TBL] [Abstract][Full Text] [Related]
6. Estrous Cycle Modulation of Feeding and Relaxin-3/Rxfp3 mRNA Expression: Implications for Estradiol Action.
de Ávila C; Chometton S; Calvez J; Guèvremont G; Kania A; Torz L; Lenglos C; Blasiak A; Rosenkilde MM; Holst B; Conrad CD; Fryer JD; Timofeeva E; Gundlach AL; Cifani C
Neuroendocrinology; 2021; 111(12):1201-1218. PubMed ID: 33333517
[TBL] [Abstract][Full Text] [Related]
7. [Relaxin 2--a pregnancy hormone involved in the process of carcinogenesis].
Domińska K
Ginekol Pol; 2013 Feb; 84(2):126-30. PubMed ID: 23668059
[TBL] [Abstract][Full Text] [Related]
8. Relaxin-related gene expression differs between anadromous and stream-resident stickleback (Gasterosteus aculeatus) following seawater transfer.
Kusakabe M; Ishikawa A; Kitano J
Gen Comp Endocrinol; 2014 Sep; 205():197-206. PubMed ID: 24973563
[TBL] [Abstract][Full Text] [Related]
9. Relaxin-3 and receptors in the human and rhesus brain and reproductive tissues.
Silvertown JD; Neschadim A; Liu HN; Shannon P; Walia JS; Kao JC; Robertson J; Summerlee AJ; Medin JA
Regul Pept; 2010 Jan; 159(1-3):44-53. PubMed ID: 19778557
[TBL] [Abstract][Full Text] [Related]
10. The relaxin receptor as a therapeutic target - perspectives from evolution and drug targeting.
Bathgate RAD; Kocan M; Scott DJ; Hossain MA; Good SV; Yegorov S; Bogerd J; Gooley PR
Pharmacol Ther; 2018 Jul; 187():114-132. PubMed ID: 29458108
[TBL] [Abstract][Full Text] [Related]
11. Relaxin: new peptides, receptors and novel actions.
Bathgate RA; Samuel CS; Burazin TC; Gundlach AL; Tregear GW
Trends Endocrinol Metab; 2003 Jul; 14(5):207-13. PubMed ID: 12826326
[TBL] [Abstract][Full Text] [Related]
12. Relaxin family peptide receptors--former orphans reunite with their parent ligands to activate multiple signalling pathways.
Halls ML; van der Westhuizen ET; Bathgate RA; Summers RJ
Br J Pharmacol; 2007 Mar; 150(6):677-91. PubMed ID: 17293890
[TBL] [Abstract][Full Text] [Related]
13. Increased feeding and body weight gain in rats after acute and chronic activation of RXFP3 by relaxin-3 and receptor-selective peptides: functional and therapeutic implications.
Ganella DE; Ryan PJ; Bathgate RA; Gundlach AL
Behav Pharmacol; 2012 Sep; 23(5-6):516-25. PubMed ID: 22854307
[TBL] [Abstract][Full Text] [Related]
14. Distribution of relaxin-3 and RXFP3 within arousal, stress, affective, and cognitive circuits of mouse brain.
Smith CM; Shen PJ; Banerjee A; Bonaventure P; Ma S; Bathgate RA; Sutton SW; Gundlach AL
J Comp Neurol; 2010 Oct; 518(19):4016-45. PubMed ID: 20737598
[TBL] [Abstract][Full Text] [Related]
15. Japanese medaka as a model for studying the relaxin family genes involved in neuroendocrine regulation: Insights from the expression of fish-specific rln3 and insl5 and rxfp3/4-type receptor paralogues.
Alnafea H; Vahkal B; Zelmer CK; Yegorov S; Bogerd J; Good SV
Mol Cell Endocrinol; 2019 May; 487():2-11. PubMed ID: 30703485
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of relaxin-3 and a selective relaxin-3 receptor agonist on food and water intake and hypothalamic neuronal activity in rats.
de Ávila C; Chometton S; Lenglos C; Calvez J; Gundlach AL; Timofeeva E
Behav Brain Res; 2018 Jan; 336():135-144. PubMed ID: 28864207
[TBL] [Abstract][Full Text] [Related]
17. Insulin-relaxin family peptide signaling and receptors in mouse brain membranes and neuronal cells.
Ortinau S; Lin F; Wade JD; Tregear GW; Bathgate RA; Gundlach AL
Ann N Y Acad Sci; 2005 May; 1041():211-5. PubMed ID: 15956710
[TBL] [Abstract][Full Text] [Related]
18. Relaxin family peptides and their receptors.
Bathgate RA; Halls ML; van der Westhuizen ET; Callander GE; Kocan M; Summers RJ
Physiol Rev; 2013 Jan; 93(1):405-80. PubMed ID: 23303914
[TBL] [Abstract][Full Text] [Related]
19. International Union of Pharmacology LVII: recommendations for the nomenclature of receptors for relaxin family peptides.
Bathgate RA; Ivell R; Sanborn BM; Sherwood OD; Summers RJ
Pharmacol Rev; 2006 Mar; 58(1):7-31. PubMed ID: 16507880
[TBL] [Abstract][Full Text] [Related]
20. Comparative localization of leucine-rich repeat-containing G-protein-coupled receptor-7 (RXFP1) mRNA and [33P]-relaxin binding sites in rat brain: restricted somatic co-expression a clue to relaxin action?
Ma S; Shen PJ; Burazin TC; Tregear GW; Gundlach AL
Neuroscience; 2006 Aug; 141(1):329-44. PubMed ID: 16725278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
